Article
Fbxo45-mediated NP-STEP46 degradation via K6-linked ubiquitination sustains ERK activity in lung cancer.
Molecular oncology - 1 Aug 2022
Wang Qian, Xu Ci, Cai Renjie, An Weishu, Yuan Haihua, Xu Ming
Abstract excerpt
Lung cancer is one of the most threatening malignant tumors to human health. Epidermal growth factor receptor (EGFR)-targeted therapy is a common and essential means for the clinical treatment of lung cancer. However, drug resistance has always affected the therapeutic effect and survival rate in non-small cell lung cancer (NSCLC). Tumor heterogeneity is a significant reason, yielding various drug resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
